About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Proton Therapy for Unresectable Cancer (CA) of Pancreas

NCT00685763·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Florida

Chemotherapy:Capecitabine on radiation days Proton radiation over 7 weeks Consolidation Chemotherapy:Gemcitabine

Age

18–100

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Pathologically confirmed adenocarcinoma of the pancreas.
Patients must be medically inoperable or have unresectable disease

You may not be if

Evidence of distant metastasis; evidence of metastatic disease in the major viscera (organs), peritoneal seeding and/or ascites.
Previous irradiation to the abdomen that would compromise the ability to deliver the prescribed treatment.
Prior surgical resection.

The record

StatusCompleted

PhaseNo phase

Taking part13

StartedMar 2008

UpdatedAug 24, 2017

Conditions

Pancreatic Cancer

Where1

University of Florida Proton Therapy Institute
Jacksonville, Florida, United States

Clareo Health | Proton Therapy for Unresectable Cancer (CA) of Pancreas